Cindy Xia
VP, Translational Sciences @City Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
VP, Translational Sciences @City Therapeutics
Cambridge, MA, US
Leading cross-functional teams of PK/Clinical Pharmacology, Nonclinical Safety Evaluation, and Bioanalysis/Biotransformation to support drug discovery and development- Driving translational strategies, IND-enabling studies, and regulatory submissions to bridge preclinical research and clinical development.
EDUCATION
Peking University
Bachelor's degree in Pharmaceutic Science and Master in Medicinal Chemistry
University of Southern California
Doctor of Philosophy (Ph.D.)
ABOUT CINDY XIA
Bringing over two decades of experience in drug discovery and development, I am a strategic and innovative leader committed to advancing the field through collaboration and innovation. My expertise includes defining and implementing DMPK, ADMET, bioanalytics, and translational research efforts at various stages of drug discovery and development for diverse platforms and modalities, such as mRNA, siRNA, biologics, small molecules, and cell and gene therapies.I have a strong track record of building and leading high-performing, cross-functional teams, fostering a collaborative environment. My proven ability to design target product profiles and develop non-clinical development strategies has advanced compounds from discovery to clinical trials. I effectively lead, communicate, and leverage multidisciplinary expertise to achieve goals professionally and timely.My proficiency in regulatory guidelines enables me to provide scientifically sound justifications for actions. I have led DMPK/non-clinical activities for over 40 INDs/CTAs and 5 NDAs/MAAs, including Velcade, Ninlaro, Alunbrig, Exkivity, and Livtencity. I am enthusiastic about contributing to the scientific field by organizing conferences and workshops and have authored over 50 research papers and reviews.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.